Clinical Study
Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma
| | Total adverse events | Treated with bortezomib | Treated with lenalidomide | Treated with other agents |
| | Fatigue | 2 | 0 | 2 | 0 | | Deep vein thrombosis | 1 | 0 | 1 | 0 | | Thrombocytopenia | 13 | | | | | Grade I/II | | 5 | | 2 | | Grade III/IV | | | 6 | | | Anemia | 11 | 0 | 9 | 2 | | Exacerbation of Crohn’s disease | 1 | 0 | 1 | 0 | | Mucositis grade II | 3 | 2 | 1 | 0 | | Nausea grade II | 11 | 2 | 8 | 1 | | Diarrhea grade I/II | 3 | 2 | 1 | 0 | | Dermatological toxicity | 3 | 3 | 0 | 0 |
|
|
